Jupiter Neurosciences, Inc. (JUNS): Market Value
Jupiter Neurosciences Inc (JUNS) currently relies on external capital, as drug development is in its early stages and cash flow remains negative. The business is based on the Jotrol platform, which creates a unique environment for delivering neuroprotectors to the brain. This chart illustrating a market valuation of 0.00 highlights the profit potential from selling resveratrol-based dementia therapies through government healthcare systems.
JUNS (Jupiter Neurosciences, Inc.): analytical breakdowns and indicator data
- stock price and consensus target price:
- stock exchange capitalization data:
- book value of equity indicators:
- company total debt and liquidity indicators:
Total Debt to Capital Jupiter Neurosciences Inc|JUNS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Jupiter Neurosciences Inc|JUNS - Company Aggregate Debts|Debt to Book Capitalization Ratio Jupiter Neurosciences Inc|JUNS - Company Long-Term Loans and Borrowings|Company Short-Term Debt Jupiter Neurosciences|Quick Liquidity jupiterneurosciences.com
- business earnings and investment ratios data:
JUNS - Profit After Payment of Taxes|Future Profit Jupiter Neurosciences Inc|JUNS - P/E Multiple|Future Price to Earnings Jupiter Neurosciences|JUNS - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple Jupiter Neurosciences Inc|JUNS - Operating income before deduction of amortization|Net earnings per share for the last 12 months Jupiter Neurosciences|JUNS - Earnings per share for the last four quarters|Quarterly EPS earnings growth jupiterneurosciences.com|JUNS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc
Fundamental company analysis:JUNS (Jupiter Neurosciences)
Jupiter Neurosciences Inc (JUNS) is developing the unique JOTROL platform featuring high resveratrol bioavailability. The total value of all outstanding shares determines the company's market capitalization. This metric measures market confidence in the assets, smoothing out random price spikes. Inelastic demand for the drug should ensure long-term growth of this indicator. However, impulsive buying at the peaks of the chart risks freezing investor capital.
Key competitors
Biogen - Market Valuation|Market Capitalization Neurocrine NBIX|RGC - Market Value|AXSM (Axsome Corp) - Market Capitalization|ACADIA Pharmaceuticals (ACAD) - Market Value|XENE - Market Capitalization|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Market Value|Market Value Anavex Life Sciences Corp (AVXL)|Market Value CeriBell, Inc.|PRTA (Prothena Corp) - Market Value|Market Valuation ALEC (Alector, Inc.)|Market Capitalization Annexon Biosciences (ANNX)|Market Value Omeros OMER|NGNE (Neurogene Therapeutics) - Market Valuation|AC Immune - Market Capitalization|Market Capitalization voyagertherapeutics.com VYGR|NMRA (Neumora Therapeutics, Inc.) - Market Valuation|SCLX: Market Value|TVGN (Tevogen Bio Holdings, Inc.) - Market Capitalization|Market Value Alpha Cognition Corp ACOG|Market Value Cognition Therapeutics, Inc. (CGTX)|IKT (inhibikase.com) - Market Value|Cassava Sciences - Market Valuation|Market Value ASRT|COYA - Market Value|VTGN (Vistagen Therapeutics) - Market Capitalization|OVID: Market Capitalization|Market Value acumenpharm.com (ABOS)|Market Valuation CRVO|Market Capitalization Alterity Therapeutics Ltd|Market Value Clene Inc. (CLNN)|PEPG (pepgen.com) - Market Value|Market Value Relmada Therapeutics RLMD|annovisbio.com (ANVS) - Market Value|GRCE - Market Value|Market Capitalization Firefly Neuroscience, Inc. AIFF|KLTO: Market Capitalization|Market Valuation NeuroSense Therapeutics Ltd.|RVPH (Reviva Pharmaceuticals) - Market Capitalization|MetaVia, Inc. (MTVA) - Market Capitalization|Market Capitalization NRXS|HSDT - Market Value|Market Value Passage Bio PASG|NEUP: Market Capitalization|Minerva Neurosciences - Market Capitalization|athira.com (ATHA) - Market Valuation|ADXN: Market Capitalization|Market Value Alzamend Neuro (ALZN)|Market Value Cyclerion Therapeutics Inc.|Protagenic (PTIX) - Market Capitalization|Market Valuation KTTA (Pasithea Therapeutics)|CRGT (cortigent.com) - Market Value|Market Capitalization ATXI (Avenue Therapeutics, Inc.)|Market Capitalization Brainstorm Cell Therapeutics Inc. (BCLI)|CARA - Market Value|CHRO (Chromocell) - Market Capitalization|ELYM: Market Capitalization|Market Valuation Intra-Cellular Therapies, Inc.|Market Value Longboard Pharmaceuticals, Inc.|MRNS (Marinus Pharmaceuticals Inc) - Market Value|Market Valuation NKGN (NKGen)|Market Capitalization NeuroBo Pharma (NRBO)|Market Value Sage Therapeutics, Inc. SAGE|SNPX: Market Capitalization|TRVN - Market Value|Market Capitalization Vigil Neuroscience VIGL|Anew Medical, Inc. (WENA) - Market Value|Market Capitalization CERE
